Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes.

    ... Myelodysplastic syndromes (MDS) represent a collection of stem cell disorders ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. The epidemiology of myelodysplastic syndromes.

    ... The incidence of the myelodysplastic syndromes (MDS) in the United States is reported as 3.4 per 100,000 ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Patient selection for transplantation in the myelodysplastic syndromes.

    ... remains the only known curative procedure for the myelodysplastic syndromes (MDS). Because the median age at diagnosis for MDS is in the late ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes.

    ... decitabine --to patients with aggressive forms of myelodysplastic syndromes (MDS). However, there continues to be uncertainty about the ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Hypomethylating agents in myelodysplastic syndromes changing the inevitable: the value of azacitidine as maintenance therapy, effects on transfusion and combination with other agents.

    ... of DNA hypermethylation in the pathogenesis of myelodysplastic syndromes (MDS) provides a rationale for using hypomethylating agents such ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. The role of iron chelation therapy for patients with myelodysplastic syndromes.

    ... chelation therapy in the management of patients with myelodysplastic syndromes (MDS) is currently controversial. Some investigators interpret ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.

    ... in patients with IPSS Low- and Intermediate-1 risk myelodysplastic syndromes (MDS) and evidence of iron overload . Twenty-four heavily ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Iron chelation therapy in myelodysplastic syndromes.

    ... Myelodysplastic syndromes (MDS) are a heterogeneous disorder of the hematopoietic stem ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Thrombocytopenia in patients with myelodysplastic syndromes.

    ... Thrombocytopenia , common in leukemias and myelodysplastic syndromes (MDS), is responsible for increased risk of bleeding and delay ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.

    ... System (IPSS) intermediate-2 (Int-2) and high-risk myelodysplastic syndromes (MDS), establishing it as an important new treatment for these ...

    Research Article last updated 07/20/2018 - 5:14pm.